OMX Helsinki — S&P 500 — DAX — NASDAQ 100 — STOXX 600 — EUR/USD — EUR/SEK — BTC/USD — ETH/USD — Euribor 3M — Euribor 12M —
Boston Consulting Group

Boston Consulting Group

Leadership, growth and business development 181,000 subscribers

Will AI Finally Defeat Chronic Diseases Like Alzheimer’s? | Imagine This

10.06.2025 855 views
Published: 10.06.2025 Category: Leadership, growth and business development Views: 855

Episode details

Episode description

The pharmaceutical industry has yet to develop highly effective treatments for common chronic and neurological issues, like Alzheimer’s and cardiovascular disease. But GenAI promises to accelerate the discovery and development of breakthrough treatments. BCG’s Priya Chandran explores possible new approaches and how breakthrough drugs can be made more affordable and more available to the patients who need them. Listen on podcast platforms: https://lnk.to/so-what-general-show12 Learn More: Priya Chandran: https://on.bcg.com/3ZZO5ad BCG’s Latest Thinking on the Health Care Industry: https://on.bcg.com/4kFxhxH Biopharma Trends 2025: https://on.bcg.com/4mX6CxN

Open the AI assistant chat. The chat loads only when you open it.